Applied BioSciences Expands TherPet Line with Equine Care Line
LOS ANGELES, CA / ACCESSWIRE / May 9, 2018 / Applied BioSciences Corp. (OTCQB: APPB), a diversified cannabinoid therapeutics company focused on the medical, bioceutical and pet health industries, today announced that the Company's wholly-owned animal health subsidiary TherPet has entered the equine health space with the launch of a new full-spectrum hemp-derived cannabidiol ("CBD") supplement formulated specifically for a horse's health and wellness.
TherPet's Equine Care CBD line is a natural supplement designed to play a key role in keeping horses, healthy, looking good and performing their best. Our Equine Care CBD products support healthy skin, joints and immune system as well as to ease the discomfort of fatigued muscles, stiff joints and arthritis pain.
Like humans, horses also have an endocannabinoid system comprised of cannabinoid receptors that help regulate a wide variety of bodily functions ranging from pain relief to mood.
"Regularly supplementing a horse's endocannabinoid system with full-spectrum CBD enables horses to better control inflammatory responses naturally," noted JJ Southard, Vice President of Products at Applied BioSciences Corp. "Despite millions of spectators tuning in to watch twenty of the fastest thoroughbred horses compete in the Kentucky Derby this past weekend, very few of them realize or consider the race-induced inflammation and injuries that take place during such an event."
David Horohov, Ph.D., William Robert Mills Chair at the University of Kentucky's Gluck Equine Research Center, believesthat horses as a breed are not necessarily becoming more fragile, but rather more susceptible to injury due to breeding strategies, training methods, and increased drug use. The Company hopes to reverse this trend by making Therpet's new treatment options available immediately for veterinarians, trainers, and equestrians.
Therpet's Equine Care tincture is available in a 4800 mg concentration which is packaged in a 4 fl. Oz. (120ml) bottle. The tincture is a naturally formulated Apple flavor, made with lab tested, CO2 extracted, pure full-spectrum CBD oil sourced from pesticide-free, Colorado grown hemp and specially formulated to be the highest bioavailability CBD products in the marketplace.
TherPet products are USDA NOP certified organic, non-GMO, vegan, paleo, gluten-free, sugar-free and THC-free. The products are formulated with organic 99%+ pure cannabidiol along with our proprietary blend of certified organic botanical, herbal and essential oils to further optimize bioavailability.
About Applied BioSciences Corp.
Applied BioSciences Corp. (www.appliedbiocorp.com), is a diversified company focused on multiple areas of the medical, bioceutical and pet health industry. As a leading company in the CBD and Pet health space, the company is currently shipping to the majority of US states as well as to 5 International countries. The company is focused on select investment, consumer brands, and partnership opportunities in the recreational, health and wellness, nutraceutical, and media industries.
The company has several strategic partnerships and investments currently in place and is actively pursuing additional partnerships and strategic growth opportunities.
To be added to the Applied BioSciences email distribution list, please email firstname.lastname@example.org with APPB in the subject line.
Official Website: www.appliedbiocorp.com
Facebook @remedicbd & @therpetcbd
Instagram @remedicbd & @therpet
Twitter @remedishop & @therpet
Safe Harbor Statement
Except for historical information contained herein, statements in this release may be forward-looking and made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words such as "anticipate", "believe", "estimate", "expect", "intend" and similar expressions, as they relate to Applied Biosciences Corp. (the "Company") or its management, identify forward-looking statements. These statements are based on current expectations, estimates and projections about the Company's business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including those described above and those risks discussed from time to time in the Company's filings with the Securities and Exchange Commission. Factors which could cause actual results to differ materially from these forward-looking statements include such factors as (i) the development and protection of our brands and other intellectual property, (ii) the need to raise capital to meet business requirements, (iii) significant fluctuations in marketing expenses, (iv) the ability to achieve and expand significant levels of revenues, or recognize net income, from the sale of our products and services, (v) the Company's ability to conduct the business if there are changes in laws, regulations, or government policies related to cannabis, (vi) management's ability to attract and maintain qualified personnel necessary for the development and commercialization of its planned products, and (vii) other information that may be detailed from time to time in the Company's filings with the United States Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
SOURCE: Applied BioSciences Corp.
Released May 9, 2018